S'abonner

Development of a novel peptide microarray for large-scale epitope mapping of food allergens - 20/08/11

Doi : 10.1016/j.jaci.2009.05.024 
Jing Lin, PhD a, , Ludmilla Bardina, MSc a, Wayne G. Shreffler, MD, PhD a, Doerthe A. Andreae, MD a, Yongchao Ge, PhD b, Julie Wang, MD a, Francesca M. Bruni, MD c, Zhiyan Fu, PhD a, Youngshin Han, PhD d, Hugh A. Sampson, MD a
a Pediatric Allergy and Immunology, Mount Sinai School of Medicine, New York, NY 
b Department of Neurology, Mount Sinai School of Medicine, New York, NY 
c University of Verona, Verona, Italy 
d School of Medicine, Sungkyunkwan University, Seoul, Korea 

Reprint requests: Jing Lin, PhD, Pediatric Allergy and Immunology, Mount Sinai School of Medicine, Box 1198, New York, NY 10029-6574.

Abstract

Background

The peptide microarray is a novel assay that facilitates high-throughput screening of peptides with a small quantity of sample.

Objective

We sought to use overlapping peptides of milk allergenic proteins as a model system to establish a reliable and sensitive peptide microarray-based immunoassay for large-scale epitope mapping of food allergens.

Methods

A milk peptide microarray was developed by using commercially synthesized peptides (20-mers, 3 offset) covering the primary sequences of ⍺s1-casein, ⍺s2-casein, β-casein, κ-casein, and β-lactoglobulin. Conditions for printing and immunolabeling were optimized using a serum pool of 5 patients with milk allergy. Reproducibility of the milk peptide microarray was evaluated using replicate arrays immunolabeled with the serum pool, whereas specificity and sensitivity were assessed by using serial dilution of the serum pool and a peptide inhibition assay.

Results

Our results show that epitopes identified by the peptide microarray were mostly consistent with those identified previously by SPOT membrane technology, but with specific binding to a few newly identified epitopes of milk allergens. Data from replicate arrays were reproducible (r ≥ 0.92) regardless of printing lots, immunolabeling, and serum pool batches. Using the serially diluted serum pool, we confirmed that IgE antibody binding detected in the array was specific. Peptide inhibition of IgE binding to the same peptide and overlapping peptides further confirmed the specificity of the array.

Conclusion

A reliable peptide microarray was established for large-scale IgE epitope mapping of milk allergens, and this robust technology could be applied for epitope mapping of other food allergens.

Le texte complet de cet article est disponible en PDF.

Key words : Epitope mapping, peptide microarray, allergy, milk allergen

Abbreviations used : DFU, DMSO, PPB, MAD, PBST, TMeV


Plan


 Y.H. was supported by the Korea Research Foundation Grant funded by the Korean Government (MOEHRD; KRF-2006-214-C00099). H.A.S. and J.L. were supported in part by a grant from National Institute of Allergy and Infectious Diseases (AI-44236). Studies were supported in part by grants from the National Institute of Allergy and Infectious Diseases (AI-44236) and the National Center for Research Resources (MO1-RR-00071).
 Disclosure of potential conflict of interest: W. G. Shreffler receives grant support from the Food Allergy and Anaphylaxis Network. Y. Han receives grant support from the Korean Research Foundation. H. A. Sampson is a consultant for and 4% shareholder in Allertein Pharmaceuticals, LLC; is on the advisory Board for Schering-Plough; receives grant support from the Food Allergy Initiative and the National Institute of Allergy and Infectious Diseases/National Institutes of Health; is a consultant/scientific advisor for the Food Allergy Initiative; is president of the American Academy of Allergy, Asthma & Immunology; and is 45% owner of Herbal Springs, LLC. The rest of the authors have declared that they have no conflict of interest.
 This is the first article describing the optimization and validation of the peptide microarray-based immunoassay. It provides solid tools for current and future research for mapping of allergenic epitopes.


© 2009  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 124 - N° 2

P. 315 - août 2009 Retour au numéro
Article précédent Article précédent
  • Concurrent blockade of platelet-activating factor and histamine prevents life-threatening peanut-induced anaphylactic reactions
  • Katherine Arias, Moiz Baig, Marc Colangelo, Derek Chu, Tina Walker, Susanna Goncharova, Anthony Coyle, Peter Vadas, Susan Waserman, Manel Jordana
| Article suivant Article suivant
  • Food allergy and food allergy attitudes among college students
  • Matthew J. Greenhawt, Andrew M. Singer, Alan P. Baptist

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.